Amit Sachdev, EVP, Chief Patient Officer at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 10,031 shares at $350.00 ($3.5M) on 2023-08-10, disclosed to the SEC on 2023-08-14.
Scheduled sale ($3.5M) by EVP, Chief Patient Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| VRTX | SELL | 2024-05-17 | $14K | — | Filing → |
| VRTX | SELL | 2024-02-27 | $2.6M | — | Filing → |
| VRTX | SELL | 2024-02-23 | $2.7M | — | Filing → |